This Slideshare introduces CMAP-Pro to Practice Managers and Administrators explaining how the device helps doctors improve outcomes for patients with soft tissue injuries, while increasing profit for the practice, and also shares 5 keys to easy implementation into your practice workflow. TO SEE TO LIVE PRESENTATION GO TO: https://nvmanagementcorp.com/cmap-perfect-auto-webinaripqpl961
The CMAP-Pro protocols capture the activity and function of specific muscle and nerve groups involved in soft tissue injuries.
FDA-approved in 2012, CMAP-Pro patient results have been validated through published clinical studies and featured in several peer reviewed journal articles.
A study was conducted with 114 consecutive patients with musculoskeletal pain claims results indicated a 6.9 times increase in the odds of case closure when there was concordance between CMAP-Pro results & the physicians independent diagnosis.
CMAP-Pro is indicated for use with:
Sprains or strains of the spine or limbs after 4 weeks without improvement; Upon consideration of upper or lower extremities; upon diagnosis of Carpal Tunnel Syndrome / Median Nerve Dysfunction; Upon diagnosis of Fibromyalgia, Myofascial Pain, Chronic Fatigue Syndrome; At symptom onset of Cumulative trauma disorder; Prior to or as part of the evaluation of Agreed Medical Evaluation / Qualified Medical Evaluation / Independent Medical Evaluation; At onset of new claim of patients with recurrent soft tissue claims; All neck and back cases when surgery considered; when symptoms do not match the description of injury/accident (ambiguous etiology); when trying to determine whether or not an injury is work related (causation analysis); when presence of pathology is in doubt (claims of an uncertain nature); to determine permanent and stationary (P&S) status or maximum medical improvement (MMI) in unexplained delayed return to work (RTW) claims; Prior to release of patient to modified duty to objectively define transitional/modified duties.